Expertise in
7
conditions

Dr. Robert W. Reindollar

Gastroenterology
Office
16455 Statesville Rd Ste 144, 
Huntersville, NC 
Accepting New Patients
Offers Telehealth
Expertise in
7
conditions
Office
16455 Statesville Rd Ste 144, 
Huntersville, NC 

Overview

Robert Reindollar is a Gastroenterologist practicing medicine in Huntersville, North Carolina.

Dr. Reindollar is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Nonalcoholic Steatohepatitis (NASH), Endoscopy, and Gastrectomy.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 5 clinical trials. Dr. Reindollar is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in NC

Hospital Affiliations

Novant Health Rowan Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Office
16455 Statesville Rd Ste 144, Huntersville, NC 28078

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Completed
Publish Date: August 19, 2026
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

8 Total Publications

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.
Journal: Journal of viral hepatitis
Published: October 16, 2018
Similar Doctors
Expertise in
73
conditions
Dr. Glen L. Portwood
Gastroenterology
Expertise in
73
conditions
Dr. Glen L. Portwood
Gastroenterology
Referral may be required

Southeast Stone Center

705 Griffith St Ste 205, 
Davidson, NC 
 (6.6 miles away)
704-799-2750
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Glen Portwood is a Gastroenterologist practicing medicine in Davidson, North Carolina. Dr. Portwood is highly rated in 73 conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Congenital Diaphragmatic Hernia, Esophagitis, Gastrectomy, and Colonoscopy. Dr. Portwood is currently accepting new patients.

Expertise in
72
conditions
Dr. Tarun K. Narang
Gastroenterology
Expertise in
72
conditions
Dr. Tarun K. Narang
Gastroenterology
Referral may be required
Before you request

Endoscopy Services Center-Billingsley

300 Billingsley Rd Ste 200, 
Charlotte, NC 
 (16.9 miles away)
704-372-7974
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tarun Narang is a Gastroenterologist practicing medicine in Charlotte, North Carolina. Dr. Narang is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Bile Duct Stricture, Endoscopy, and Gastrectomy. Dr. Narang is currently accepting new patients.

Expertise in
10
conditions
Dr. Herbert L. Bonkovsky
Gastroenterology
Expertise in
10
conditions
Dr. Herbert L. Bonkovsky
Gastroenterology
Referral may be required

Office

1 S Hawthorne Rd, 
Winston Salem, NC 
 (56.7 miles away)
336-716-3182
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Herbert Bonkovsky is a Gastroenterologist practicing medicine in Winston Salem, North Carolina. Dr. Bonkovsky is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Porphyria, Acute Hepatic Porphyria (AHP), Hepatitis, Bile Duct Cysts, and Liver Transplant. Dr. Bonkovsky is currently accepting new patients.

Frequently Asked Questions about Dr. Robert W. Reindollar

How do I make an appointment with Dr. Robert W. Reindollar?

You can book an appointment with Dr. Robert W. Reindollar by calling their office at 704-355-8850. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert W. Reindollar a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert W. Reindollar is classified as an Distinguished expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert W. Reindollar specialize in?

While Dr. Robert W. Reindollar is a Gastroenterology, they have specific expertise in Hepatitis C, Hepatitis, and Nonalcoholic Steatohepatitis (NASH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Robert W. Reindollar participate in research or clinical trials?

Yes. Dr. Robert W. Reindollar has published 8 articles and abstracts on conditions like Hepatitis C. You can view a list of Dr. Robert W. Reindollar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robert W. Reindollar accept my insurance?

Dr. Robert W. Reindollar accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 704-355-8850 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reindollar's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile